Laredo Oil, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Laredo Oil, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $9.4K | Sep 15, 2025 |
| FY2025 | May 31, 2024 | $36.5K | Sep 15, 2025 |
| FY2023 | May 31, 2023 | $0 | Sep 13, 2023 |
| FY2023 | May 31, 2022 | $667.6K | Sep 13, 2023 |
| FY2022 | May 31, 2021 | $4.59M | Sep 13, 2022 |
| FY2021 | May 31, 2020 | $8.15M | Sep 14, 2021 |
| FY2020 | May 31, 2019 | $8.48M | Aug 31, 2020 |
| FY2019 | May 31, 2018 | $9.36M | Aug 29, 2019 |
| FY2018 | May 31, 2017 | $9.82M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $10.90M | Aug 29, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $9.4K | Sep 15, 2025 |
| FY2025 | May 31, 2024 | $36.5K | Sep 15, 2025 |
| FY2023 | May 31, 2022 | ($618.6K) | Sep 13, 2023 |
| FY2022 | May 31, 2021 | ($183.4K) | Sep 13, 2022 |
| FY2021 | May 31, 2020 | $176.2K | Sep 14, 2021 |
| FY2020 | May 31, 2019 | $196.0K | Aug 31, 2020 |
| FY2019 | May 31, 2018 | $613.3K | Aug 29, 2019 |
| FY2018 | May 31, 2017 | ($278.0K) | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $272.4K | Aug 29, 2017 |
| FY2016 | May 31, 2015 | ($21.6K) | Aug 29, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($3.18M) | Sep 15, 2025 |
| FY2025 | May 31, 2024 | ($2.87M) | Sep 15, 2025 |
| FY2023 | May 31, 2023 | ($3.11M) | Sep 13, 2023 |
| FY2023 | May 31, 2022 | ($895.8K) | Sep 13, 2023 |
| FY2022 | May 31, 2021 | ($368.2K) | Sep 13, 2022 |
| FY2021 | May 31, 2020 | ($166.9K) | Sep 14, 2021 |
| FY2020 | May 31, 2019 | ($146.1K) | Aug 31, 2020 |
| FY2019 | May 31, 2018 | $98.7K | Aug 29, 2019 |
| FY2018 | May 31, 2017 | ($964.5K) | Aug 29, 2018 |
| FY2017 | May 31, 2016 | ($660.1K) | Aug 29, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($3.32M) | Sep 15, 2025 |
| FY2025 | May 31, 2024 | ($3.39M) | Sep 15, 2025 |
| FY2023 | May 31, 2023 | ($2.77M) | Sep 13, 2023 |
| FY2023 | May 31, 2022 | ($2.20M) | Sep 13, 2023 |
| FY2022 | May 31, 2021 | ($682.7K) | Sep 13, 2022 |
| FY2021 | May 31, 2020 | ($130.9K) | Sep 14, 2021 |
| FY2020 | May 31, 2019 | ($112.5K) | Aug 31, 2020 |
| FY2019 | May 31, 2018 | $118.0K | Aug 29, 2019 |
| FY2018 | May 31, 2017 | ($934.1K) | Aug 29, 2018 |
| FY2017 | May 31, 2016 | ($607.6K) | Aug 29, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | May 31, 2022 | $1.50M | Sep 13, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $1.84M | Sep 15, 2025 |
| FY2025 | May 31, 2024 | $2.90M | Sep 15, 2025 |
| FY2023 | May 31, 2023 | $2.00M | Sep 13, 2023 |
| FY2023 | May 31, 2022 | $1.18M | Sep 13, 2023 |
| FY2022 | May 31, 2021 | $119.4K | Sep 13, 2022 |
| FY2021 | May 31, 2020 | $75.0K | Sep 14, 2021 |
| FY2020 | May 31, 2019 | $77.9K | Aug 31, 2020 |
| FY2019 | May 31, 2018 | $300.1K | Aug 29, 2019 |
| FY2018 | May 31, 2017 | $369.5K | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $494.7K | Aug 29, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($1.65M) | Sep 15, 2025 |
| FY2025 | May 31, 2024 | ($632.5K) | Sep 15, 2025 |
| FY2023 | May 31, 2023 | ($1.64M) | Sep 13, 2023 |
| FY2023 | May 31, 2022 | ($1.20M) | Sep 13, 2023 |
| FY2022 | May 31, 2021 | ($1.23M) | Sep 13, 2022 |
| FY2021 | May 31, 2020 | $9.3K | Sep 14, 2021 |
| FY2020 | May 31, 2019 | $183.2K | Aug 31, 2020 |
| FY2019 | May 31, 2018 | ($224.4K) | Aug 29, 2019 |
| FY2018 | May 31, 2017 | ($63.3K) | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $308.1K | Aug 29, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | May 31, 2023 | $303 | Sep 13, 2023 |
| FY2023 | May 31, 2022 | $58.2K | Sep 13, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $1.45M | Sep 15, 2025 |
| FY2025 | May 31, 2024 | $2.80M | Sep 15, 2025 |
| FY2023 | May 31, 2023 | $5.13M | Sep 13, 2023 |
| FY2023 | May 31, 2022 | $3.70M | Sep 13, 2023 |
| FY2022 | May 31, 2021 | $2.77M | Sep 13, 2022 |
| FY2021 | May 31, 2020 | $1.62M | Sep 14, 2021 |
| FY2020 | May 31, 2019 | $357.1K | Aug 31, 2020 |
| FY2019 | May 31, 2018 | $266.4K | Aug 29, 2019 |
| FY2018 | May 31, 2017 | $377.9K | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $440.2K | Aug 29, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $14.02M | Sep 15, 2025 |
| FY2025 | May 31, 2024 | $13.99M | Sep 15, 2025 |
| FY2023 | May 31, 2023 | $10.21M | Sep 13, 2023 |
| FY2023 | May 31, 2022 | $6.50M | Sep 13, 2023 |
| FY2022 | May 31, 2021 | $5.01M | Sep 13, 2022 |
| FY2021 | May 31, 2020 | $3.49M | Sep 14, 2021 |
| FY2020 | May 31, 2019 | $2.06M | Aug 31, 2020 |
| FY2019 | May 31, 2018 | $1.84M | Aug 29, 2019 |
| FY2018 | May 31, 2017 | $2.29M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $1.79M | Aug 29, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($12.57M) | Sep 15, 2025 |
| FY2025 | May 31, 2024 | ($11.19M) | Sep 15, 2025 |
| FY2025 | May 31, 2023 | ($9.78M) | Sep 15, 2025 |
| FY2023 | May 31, 2022 | ($2.80M) | Sep 13, 2023 |
| FY2023 | May 31, 2021 | ($2.24M) | Sep 13, 2023 |
| FY2022 | May 31, 2020 | ($1.87M) | Sep 13, 2022 |
| FY2021 | May 31, 2019 | ($1.70M) | Sep 14, 2021 |
| FY2020 | May 31, 2018 | ($1.57M) | Aug 31, 2020 |
| FY2019 | May 31, 2017 | ($1.91M) | Aug 29, 2019 |
| FY2018 | May 31, 2016 | ($1.35M) | Aug 29, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($25.91M) | Sep 15, 2025 |
| FY2025 | May 31, 2024 | ($22.72M) | Sep 15, 2025 |
| FY2023 | May 31, 2023 | ($15.08M) | Sep 13, 2023 |
| FY2023 | May 31, 2022 | ($11.98M) | Sep 13, 2023 |
| FY2022 | May 31, 2021 | ($11.09M) | Sep 13, 2022 |
| FY2021 | May 31, 2020 | ($10.72M) | Sep 14, 2021 |
| FY2020 | May 31, 2019 | ($10.55M) | Aug 31, 2020 |
| FY2019 | May 31, 2018 | ($10.41M) | Aug 29, 2019 |
| FY2018 | May 31, 2017 | ($10.50M) | Aug 29, 2018 |
| FY2017 | May 31, 2016 | ($9.54M) | Aug 29, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $83.3K | Sep 15, 2025 |
| FY2025 | May 31, 2024 | $127.1K | Sep 15, 2025 |
| FY2021 | May 31, 2021 | $1.20M | Sep 14, 2021 |
| FY2021 | May 31, 2020 | $1.53M | Sep 14, 2021 |
| FY2021 | May 31, 2019 | $289.6K | Sep 14, 2021 |
| FY2020 | May 31, 2018 | $106.3K | Aug 31, 2020 |
| FY2019 | May 31, 2017 | $330.7K | Aug 29, 2019 |
| FY2018 | May 31, 2016 | $393.9K | Aug 29, 2018 |
| FY2017 | May 31, 2015 | $85.8K | Aug 29, 2017 |
| FY2016 | May 31, 2014 | $88.3K | Aug 29, 2016 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 74.77M | Sep 15, 2025 |
| FY2025 | May 31, 2024 | 71.99M | Sep 15, 2025 |
| FY2023 | May 31, 2023 | 66.22M | Sep 13, 2023 |
| FY2023 | May 31, 2022 | 54.51M | Sep 13, 2023 |
| FY2022 | May 31, 2021 | 54.51M | Sep 13, 2022 |
| FY2021 | May 31, 2020 | 54.51M | Sep 14, 2021 |
| FY2020 | May 31, 2019 | 54.51M | Aug 31, 2020 |
| FY2019 | May 31, 2018 | 54.51M | Aug 29, 2019 |
| FY2018 | May 31, 2017 | 54.51M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | 54.51M | Aug 29, 2017 |